A Therapeutic Cancer Vaccine Targeting Carcinoembryonic Antigen in Intestinal Carcinomas
- 1 February 2009
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 20 (2), 125-136
- https://doi.org/10.1089/hum.2008.116
Abstract
A genetic vaccine platform based on DNA electroporation (DNA-EP) and adenovirus (Ad) was used to generate immune response against human carcinoembryonic antigen (CEA) and antitumor effects in murine models with spontaneous tumors arising in an orthotopic location. CEA transgenic (CEA.Tg) mice treated with the carcinogen 1,2-dimethylhydrazine developed CEA-overexpressing tumors that resembled human sporadic colorectal cancer. APC1638N/CEA hybrid mice, generated by crossing mice carrying the adenomatous polyposis coli (Apc1638N) gene mutation with CEA.Tg mice, are representative of human familial polyposis and develop polyps that overexpress the antigen. In both models, the DNA-EP/Ad vaccine succeeded in breaking immune tolerance and achieved significant antitumor effects in therapeutic settings. Our data suggest that genetic vaccines targeting CEA may be feasible strategies against gut tumors that overexpress the antigen. In addition, these models are powerful systems for evaluating antigen-specific tumor immunity and assessing therapeutic vaccine strategies for human colorectal cancer.Keywords
This publication has 33 references indexed in Scilit:
- Vectors encoding carcinoembryonic antigen fused to the B subunit of heat-labile enterotoxin elicit antigen-specific immune responses and antitumor effectsVaccine, 2007
- Individual mouse analysis of the cellular immune response to tumor antigens in peripheral blood by intracellular staining for cytokinesJournal of Immunological Methods, 2006
- CD4+CD25+ regulatory T-cell-inactivation in combination with adenovirus vaccines enhances T-cell responses and protects mice from tumor challengeCancer Gene Therapy, 2006
- DNA and Adenoviral Vectors Encoding Carcinoembryonic Antigen Fused to Immunoenhancing Sequences Augment Antigen-Specific Immune Response and Confer Tumor ProtectionHuman Gene Therapy, 2006
- Heterologous Human Immunodeficiency Virus Type 1 Priming-Boosting Immunization Strategies Involving Replication-Defective Adenovirus and Poxvirus Vaccine VectorsJournal of Virology, 2004
- p53 and its co-activator p300 are inversely regulated in the mouse colon in response to carcinogen.Toxicology Letters, 2003
- Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag GeneJournal of Virology, 2003
- Human health perspective of environmental exposure to hydrazines: A reviewChemosphere, 1998
- Familial risk and colon cancerInternational Journal of Cancer, 1996
- Investigations into the metabolism and mode of action of the colon carcinogen 1, 2-dimethylhydrazineCancer, 1975